New device sucks out deadly heart infections without open surgery

NCT ID NCT07282002

Not yet recruiting Disease control Sponsor: Angiodynamics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device called AngioVac that uses suction to remove infected growths (vegetations) from the right side of the heart in people with infective endocarditis. The trial will enroll 30 adults with large vegetations and track survival, infection clearance, and complications within 30 days. If it works, it could offer a less invasive alternative to surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AngioVac System (a vacuum device to suction out infected growths from the heart)
What this could lead to: If successful, this could offer a less invasive way to remove dangerous heart infections, potentially reducing the need for open-heart surgery.
What could go wrong: This is a small, early feasibility study with only 30 participants, so results may not apply broadly. Risks include bleeding, heart perforation, or device-related complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFECTIVE ENDOCARDITIS (IE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endocarditis infective endocarditis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFECTIVE ENDOCARDITIS (IE)

More trials for these conditions

Other studies related to the condition(s) this trial covers.